Solomon Moshkevich is responsible for strategy and execution across all aspects of Natera’s oncology business, as General Manager of Oncology. Since joining Natera in 2011, Solomon has built and led multiple teams including global marketing, business development, product management, medical and scientific affairs, and international sales; and he has played a leading role in the development, clinical validation and commercial success of all Natera’s cell-free DNA products including Panorama, Prospera, and Signatera. Solomon graduated summa cum laude from Columbia University with a B.A. in Economics and Mathematics and holds an M.B.A. from Stanford University. He began his career as a consultant with Bain & Company in New York before joining the private equity investment team at Parthenon Capital in Boston; and he currently serves on the Board of Directors for the Ronald McDonald House Charities of the Bay Area.